The Strategic Advisory Board (SAB) is composed of international leaders in the fields of genomics research, medicine, and patient advocacy, and includes representatives from GA4GH host institutions and major funding bodies. The SAB provides high-level guidance and insight on areas of strategic growth and guides our direction as a thought leader on clinical and genomic data sharing.